Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
K
|
Kellanova
SWB:KEL
|
US |
|
L
|
Lumentum Holdings Inc
XETRA:LU2
|
US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
US |
|
Apollo Global Management Inc
NYSE:APO
|
US |
|
Soditech SA
PAR:ALSEC
|
FR |
|
S
|
Stora Enso Oyj
LSE:0CX9
|
FI |
|
Coro Energy Plc
LSE:CORO
|
UK |
|
C
|
Companhia Energetica de Minas Gerais CEMIG
NYSE:CIG
|
BR |
|
0
|
01 Communique Laboratory Inc
OTC:OONEF
|
CA |
|
N
|
Nusantara Sejahtera Raya Tbk PT
IDX:CNMA
|
ID |
|
Wisekey International Holding AG
NASDAQ:WKEY
|
CH |
|
SS Lazio SpA
MIL:SSL
|
IT |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
|
Perpetua Resources Corp
F:9MIB
|
US |
|
M
|
Molina Healthcare Inc
XBER:MHG
|
US |
|
Claros Mortgage Trust Inc
F:5WO
|
US |
|
MiMedia Holdings Inc
F:KH3
|
US |
|
R
|
Relx PLC
F:RDED
|
UK |
|
Shell PLC
F:R6C0
|
UK |
|
Cooper Energy Ltd
ASX:COE
|
AU |
|
S
|
SBI Holdings Inc
XMUN:ZOF
|
JP |
|
ConvaTec Group PLC
F:2CVU
|
UK |
|
U
|
UMediC Group Bhd
KLSE:UMC
|
MY |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
429.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
